Prosecution Insights
Last updated: April 19, 2026

BEIGENE, LTD.

3 pending office actions

Portfolio Summary

3
Total Pending OAs
2
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18015561 DEGRADATION OF (EGFR) BY CONJUGATION OF EGFR INHIBITORS WITH E3 LIGASE LIGAND AND METHODS OF USE JACKSON, SHAWQUIA 1626 Final Rejection Jan 11, 2023
18011590 TYK-2 INHIBITOR COLEMAN, BRENDA LIBBY 1624 Non-Final OA Dec 20, 2022
17629910 DEGRADATION OF BRUTON'S TYROSINE KINASE (BTK) BY CONJUGATION OF BTK INHIBITORS WITH E3 LIGASE LIGAND AND METHODS OF USE MOU, LIYUAN 1628 Final Rejection Jan 25, 2022

Managing BEIGENE, LTD.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month